Sammendrag fra ERS 7.-11. september 2024
Utviklingen av astma-KOLS går fremover og kolleger fra medisinsk avdeling ved Chiesi dekker den årlige europeiske lungekongressen ERS, denne gangen i Wien. I år har kunstig intelligens kommet med på kongressen med årets kongresstema Mennesker og maskiner: å få riktig balanse. Det er ingen tvil om at KI kan analysere enorme mengder data uten så mye som en kaffepause, men bruk av KI til kliniske beslutninger reiser også spørsmål om etikk og ansvar. Hvem, eller hva, tør du å stole på?
Hvordan høres det ut i en kongresshall når 20 000 lungeinteresserte samles?
Nytt:
Inflammasjon, astma og røyking
Oppnår vi likeverd med hensyn til helse i 2050?
Primary care research: Eosinophils, treatable traits and social support
Let the music play – music therapy as an adjunct to clinical care
Music therapy options, including music listening and singing may address breathlessness, anxiety and depression to boost psychological well-being and motivation to exercise in people with chronic respiratory disease. ... Läs mer
Inhaler Technique – Tricky to Master
Correct inhaler technique is tricky but crucial for treatment of asthma and COPD, as you ensure optimal delivery and deposition of the medication when mastering the device used. ... Läs mer
What is Pulmonary Rehabilitation?
The human body is built for movement, and for people living with COPD, it is particularly important to keep moving, here's why. ... Läs mer
A whole session on research from a primary care perspective!
What is a normal blood eosinophil level and are there quick fixes for improving asthma or COPD control? And can having some who cares make a difference for your health? ... Läs mer
Latest insights on COPD and cardiovascular disease
Summary of symposium Clinical year in review - COPD and cardiovascular disease: latest insights in epidemiology, detection and intervention Speakers: Borja Garcia-Cosio, Sami O. Simons, Bianca Beghè & Jennifer Quint. ... Läs mer
Smoking in patients with obstructive airway diseases: a challenge beyond COPD
Summary of ERS Symposia (September 8, 2024) covering the challenges of adolescent smoking, its harmful effects on asthma and COPD patients, and the reduced effectiveness of treatments in smokers. It highlighted that continued smoking accelerates disease progression, while quitting improves symptoms and treatment outcomes. The key message was the critical need for smoking cessation to promote better long-term health. ... Läs mer
Post-prematurity lung disease: from birth to adulthood
Globally, almost 1 in 10 births are preterm, resulting in 13-15 million preterm babies annually (1). Thankfully, the survival rates have increased dramatically in the last decades. Summary of symposium from Sept 8, 2024. ... Läs mer
Towards health equity in 2050
Health equity is a term referring to fair and just opportunity to maintain optimal health. It entails good conditions for leading healthy lives as well as access to care when in need. ... Läs mer
Digitalisation in health care
Where are we with telehealth in COPD? Potential of telehealth From the talk by Rebecca Disler, Australia, it became clear that telehealth has the potential to add new aspects to ... Läs mer
Biologics in COPD – are we there?
Current status of biologics in COPD In Professor Alberto Papi’s comprehensive lecture on the evolving landscape of biological treatment in COPD, he emphasized the proven efficacy of triple therapy in ... Läs mer
Understanding risk factors of COPD
The understanding of risk factors associated with COPD has advanced over the last 2-3 decades. Can COPD be considered anymore merely as a smoking disease? Or are there other fires ... Läs mer
Mild to moderate asthma – mechanisms and phenotyping
What do I need to know about mild and moderate asthma? Hot topics of asthma in a clinical context were covered by Professor Celeste Porsbjerg (Copenhagen, Denmark) in a presentation ... Läs mer
Digital biomarkers in asthma management
Adherence and health behaviours, can wearables help? Continuous monitoring like never before The growing connectivity in the world provides a substantial potential of digital innovations for management of various diseases ... Läs mer
Next generation evidence-based decision-making in respiratory medicine
SUMMARY: A session exploring how real-life research may aid decision-making and guideline development and complement RCT for better assessment of interventions. Bias, both in randomised controlled trials (RCT) and Real-world ... Läs mer
Longitudinal cohorts in airway disease
Due to the nature of longitudinal studies, the data and learnings obtained are as plenty as they are important and relevant. This became very clear when attending the session covering ... Läs mer
A systematic review of methods of scoring inhaler technique
Inhalation devices: Could we grade individual technique? SUMMARY: A systematic review took a look at how inhalation technique has been assessed in research, finding no standardized method to assess, and ... Läs mer
Burden of tobacco farming and use of electronic nicotine delivery system on the environment and occupational health
SUMMARY: In addition to harmful effects of smoking cigarettes, there are environmental concerns about the complete product life cycle that the tobacco industry is working intensively to downplay. Meanwhile, the ... Läs mer
GOLD guideline evolution: BC is out and Exacerbation prone is in
Reference to presentation: Current challenges in airways disease management – Evolution in GOLD: we cannot ‘see’ ‘C’ anymore and LABA/ICS are gone. Helpful or a hindrance? Speaker: Antonio Anzueto, USA ... Läs mer
Pulmonary rehabilitation in severe and very severe COPD.
Targeting treatable traits in severe chronic obstructive pulmonary disease: a nonpharmacological approach SUMMARY: Pulmonary rehabilitation should be tailor made to improve physical and mental conditions to cope with COPD. It ... Läs mer
Eldre rapporter
Vil du heller lese rapporterne som pdf?
ERS 2023
ID 7457-11.04.2024